This series on “Neonatal Jaundice” is edited by
- David K. Stevenson, PhD and Ronald J. Wong, MD, Stanford University School of Medicine, Stanford, California, USA.
Its main purposes are to provide a state-of-art review of neonatal jaundice, evidence-based data and expert opinions about how neonatal jaundice should be managed, and a perspective on what therapeutic approaches might be possible in the future.
Editorial
Newborn jaundice—an introductory overview
Review article
The epidemiology of neonatal jaundice
The contribution of genetic factors to hyperbilirubinemia and kernicterus risk in neonates: a targeted update
The biology of bilirubin production: detection and inhibition
Severe neonatal hyperbilirubinemia and the brain: the old but still evolving story
Narrative review of bilirubin measurement and binding
Hemolytic causes of neonatal jaundice: diagnosis and treatment
Bilirubin neurotoxicity: a narrative review on long lasting, insidious, and dangerous effects
Phototherapy for preterm newborns—historical controversies and RCT evidence
A narrative review of electronic clinical decision support tools for hyperbilirubinemia management
Disclosure:
The series “Neonatal Jaundice”was commissioned by the editorial office, Pediatric Medicine without any sponsorship or funding. David K. Stevenson and Ronald J. Wong served as the unpaid Guest Editor for the series.